UCD National Virus Reference Laboratory

Reason for Notification:

Please be aware that our testing schedule will be disrupted week beginning Monday the 21^st of September due to a software upgrade to our Laboratory Information System. If urgent samples are being sent, please contact the NVRL directly on 01-7164401 and select option 2. Please note that while the upgrade takes place, our results line will also be affected: as such, we anticipate that the results line will not be available until the afternoon of Monday the 21^st at the earliest.  

NVRL reference: CN-26-19

Reason for Notification:

Following the discontinuation of the Panbio Leptospira IgM assay, the NVRL is introducing the Serion ELISA classic Leptospirosis IgM assay (Virion Serion), starting the week beginning September 7^th 2026.

The new test code is LEPM.

If you have any queries about this change, please contact our Clinical team at the number below.

Phone 01-7164401, and select option 2.

NVRL reference: CN-26-18

Reason for Notification: Update to earlier Notification - posted to the website on 11th June 2026

Further to the notice posted on 11^th June 2026, the NVRL will be moving routine testing of plasma for CMV and EBV DNA to the Roche Cobas® system.

Samples received at the NVRL from 31^st July 2026 will be tested on this platform.

For Paediatric patients: please note that a larger sample volume is required for these assays, where possible please send one tube for EBV and one for CMV.

Reason for Notification:

As of the week beginning July 6th, the NVRL will return to use of the Luminex™ NxTAG v2 assay. Reporting of human metapneumovirus (hMPV) will recommence at this time.

No additional actions should be required for users, but if you have any questions, please contact the lab at the number below.

Phone 01-7164401, and select option 2.

NVRL reference: CN-26-17

Introduction of new tests for CMV and EBV at NVRL in mid-July 2026 – please refer to website notification on the NVRL website, 19^th December 2025

Reason for Notification:

Further to the previous notice issued on 19th December 2025, the NVRL will be moving routine testing of plasma for CMV and EBV DNA to the Roche Cobas® system in mid July 2026.

Reason for Notification:

On 26th March the NVRL posted a Customer Notification regarding suspension of this assay following receipt of a Field Safety Notice from the supplier, Diasorin.

We have been informed that the date of availability of this kit is now 27^th MAY 2026.

NVRL apologises for any issues to our service users; these are outside our control.

Please contact the NVRL Clinical team if you have any queries.

Phone 01-7164401, and select option 2.